Radiopharm Theranostics Limited
$1.03
-0.05 (-4.63%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -40.5%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -64.0%
Own RADX?
See how RADX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.